Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1131992-30-7

Post Buying Request

1131992-30-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1131992-30-7 Usage

General Description

6-Bromo-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine is a chemical compound with the molecular formula C6H2BrCl2N3. It is a heterocyclic compound belonging to the pyrrolopyrimidine family, and it is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. 6-BROMO-2,4-DICHLORO-7H-PYRROLO[2,3-D]PYRIMIDINE is known for its potential antiproliferative and cytotoxic activities, and it has been studied for its potential use in the treatment of cancer. Additionally, its unique structure and reactivity make it a valuable intermediate in the production of various drug candidates, making it an important compound in medicinal and chemical research.

Check Digit Verification of cas no

The CAS Registry Mumber 1131992-30-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,1,9,9 and 2 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1131992-30:
(9*1)+(8*1)+(7*3)+(6*1)+(5*9)+(4*9)+(3*2)+(2*3)+(1*0)=137
137 % 10 = 7
So 1131992-30-7 is a valid CAS Registry Number.

1131992-30-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-bromo-2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1131992-30-7 SDS

1131992-30-7Relevant articles and documents

KRAS G12C Mutant protein inhibitors

-

, (2021/11/26)

The invention discloses compounds which irreversibly inhibit KRAS G12C mutation. A pharmaceutically acceptable salt and of the compound contains the compound or a salt thereof, and the invention also discloses an application of the compound or a salt and of the compound in the treatment KRAS G12C of a proliferative disease such as a sudden tumor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1131992-30-7